Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02333864 · ClinicalTrials.gov registry record
POGO® Automatic Blood Glucose Monitoring System Clinical Study
A clinical trial of Diabetes Mellitus, sponsored by Intuity Medical.
- Completed
- Registry status
- 287
- Enrollment target
- 2
- Study locations
NCT02333864: Completed study of Diabetes Mellitus, sponsored by Intuity Medical.
NCT02333864 is a study of Diabetes Mellitus that has completed, run by Intuity Medical. The registered enrollment target is 287 participants, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (85% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02333864, a study of Diabetes Mellitus, has completed, sponsored by Intuity Medical.
- COMPLETED
- Registry status
- 287 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine if the POGO® system delivers accurate blood glucose readings in the hands of the lay user and assess the POGO® system accuracy when used by trained health care professionals.
Primary Outcome
Lay-user accuracy
Conditions Studied
Interventions
- DEVICE POGO® BGMS
Study Locations (2)
California
- Diablo Clinical Reasearch - Walnut Creek
Minnesota
- Park Nicollett Institute - International Diabetes Center - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 287 participants |
| Start Date | 2014-12 |
| Est. Completion | 2015-03 |
What the finished NCT02333864 record still lists
NCT02333864 is an observational study that tracks outcomes without assigning an intervention. The registered 287 participants enrollment target is mid-sized for trials with a published cap, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which POGO® BGMS is the first listed.
NCT02333864 reports a single indexed study location in California, Minnesota.
Frequently Asked Questions
What is clinical trial NCT02333864 about?
NCT02333864 is a clinical study titled "POGO® Automatic Blood Glucose Monitoring System Clinical Study". The purpose of this study is to determine if the POGO® system delivers accurate blood glucose readings in the hands of the lay user and assess the POGO® system accuracy when used by trained health care professionals.
What is the current status of trial NCT02333864?
This trial is currently completed. The enrollment target is 287 participants. The study started on 2014-12. Estimated completion is 2015-03.
What conditions does trial NCT02333864 study?
This clinical trial studies the following conditions: Diabetes Mellitus.
What interventions are being tested in trial NCT02333864?
The interventions under investigation include: POGO® BGMS (DEVICE).
Who is sponsoring clinical trial NCT02333864?
This trial is sponsored by Intuity Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02333864 being conducted?
This trial has 2 study locations across California, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02333864's enrollment target sits among peer trials
287 71st of 208 higher than 138 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Genetic Studies of Insulin and Diabetes
RECRUITING
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
RECRUITING
-
Genetics Of Autoimmunity In Type I Diabetes
RECRUITING
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03094429 · 287 participants · Phase 2
An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults
- NCT06385080 · 287 participants · Phase 1
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
- NCT06919224 · 287 participants · NA
Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
- NCT02098265 · 288 participants · NA
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia